Related references
Note: Only part of the references are listed.Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre
Jesus Loarce-Martos et al.
RHEUMATOLOGY (2021)
Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort
Csilla Andras et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level
R. Aggarwal et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)
Risk Factors and Cancer Screening in Myositis
Siamak Moghadam-Kia et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies
Shanshan Li et al.
CLINICAL RHEUMATOLOGY (2019)
The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis
Audrey Aussy et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
Z. Betteridge et al.
JOURNAL OF AUTOIMMUNITY (2019)
18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications
Peter G. Maliha et al.
NUCLEAR MEDICINE COMMUNICATIONS (2019)
Clinical value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis
Sei-ichiro Motegi et al.
JOURNAL OF DERMATOLOGY (2019)
Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis
Paul M. Hoesly et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis
Avery Kundrick et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients
M. Best et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay
Li Wang et al.
CLINICAL RHEUMATOLOGY (2018)
The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study
Chong Hong Lim et al.
SAGE OPEN MEDICINE (2018)
The EuroMyositis registry: an international collaborative tool to facilitate myositis research
James B. Lilleker et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study
Gerd Cecilie Dobloug et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis
Angela Ceribelli et al.
CLINICAL RHEUMATOLOGY (2017)
Risk of Malignancy in Dermatomyositis and Polymyositis: A Systematic Review and Meta-Analysis
Judy K. Qiang et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2017)
A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies
Iago Pinal-Fernandez et al.
RHEUMATOLOGY (2017)
Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain
Laura Nuno-Nuno et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Endoscopy is of low yield in the identification of gastrointestinal neoplasia in patients with dermatomyositis: A cross-sectional study
Trilokesh D. Kidambi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients
Anna Rogers et al.
ARTHRITIS CARE & RESEARCH (2017)
Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients
Jemima Albayda et al.
ARTHRITIS CARE & RESEARCH (2017)
An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis
Zhen-guo Huang et al.
PLOS ONE (2017)
Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
Hanbo Yang et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment
Alexander Oldroyd et al.
CLINICAL MEDICINE (2017)
Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort
F. Galimberti et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors
Mariko Ishizuka et al.
MODERN RHEUMATOLOGY (2016)
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody
Yves Allenbach et al.
BRAIN (2016)
Malignancy in dermatomyositis and polymyositis: analysis of 192 patients
Yao-Fan Fang et al.
CLINICAL RHEUMATOLOGY (2016)
Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis
Manabu Fujimoto et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2016)
Anti-TIF1-γ antibody and cancer-associated myositis A clinicohistopathologic study
Ayumi Hida et al.
NEUROLOGY (2016)
Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies
Naoki Mugii et al.
PLOS ONE (2016)
Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis
Eun Ha Kang et al.
RHEUMATOLOGY (2016)
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis
David F. Fiorentino et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort
Gerd Cecilie Dobloug et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
Satoshi Ikeda et al.
SPRINGERPLUS (2015)
Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis
Kohei Azuma et al.
Modern Rheumatology (2014)
Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort
Rossella Neri et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Complex repetitive discharge on electromyography as a risk factor for malignancy in idiopathic inflammatory myopathy
Na Ri Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ
David F. Fiorentino et al.
ARTHRITIS AND RHEUMATISM (2013)
Incidence of malignancies in biopsy-proven inflammatory myopathy
Meena A. Kannan et al.
NEUROLOGY INDIA (2013)
Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome
Yasuhito Hamaguchi et al.
PLOS ONE (2013)
The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis
Vidya Limaye et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays
Moises Labrador-Horrillo et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
Yuki Ichimura et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Comparison of long-term outcome between anti-Jo1-and anti-PL7/PL12 positive patients with antisynthetase syndrome
I. Marie et al.
AUTOIMMUNITY REVIEWS (2012)
Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2
Asuka Ishikawa et al.
RHEUMATOLOGY (2012)
Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis A Multicenter Cross-sectional Study
Yasuhito Hamaguchi et al.
ARCHIVES OF DERMATOLOGY (2011)
Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study
C. -F. Kuo et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients
Nobuaki Ikeda et al.
JOURNAL OF DERMATOLOGY (2011)
Idiopathic Inflammatory Myopathy Associated with Malignancy: A Retrospective Cohort of 151 Korean Patients with Dermatomyositis and Polymyositis
Min Wook So et al.
JOURNAL OF RHEUMATOLOGY (2011)
Conventional Cancer Screening versus PET/CT in Dermatomyositis/Polymyositis
Albert Selva-O'Callaghan et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
Eun Ha Kang et al.
BMC MUSCULOSKELETAL DISORDERS (2010)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Cancer-Associated Myositis and Anti-p155 Autoantibody in a Series of 85 Patients With Idiopathic Inflammatory Myopathy
Ernesto Trallero-Araguas et al.
MEDICINE (2010)
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Kei Hoshino et al.
RHEUMATOLOGY (2010)
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
Yi-Ju Chen et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Outlier and influence diagnostics for meta-analysis
Wolfgang Viechtbauer et al.
RESEARCH SYNTHESIS METHODS (2010)
Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study
Y. L. Huang et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Malignancy Is Associated with Dermatomyositis But Not Polymyositis in Northern New England, USA
Brendan B. Antiochos et al.
JOURNAL OF RHEUMATOLOGY (2009)
Factors Associated With Underlying Malignancy in a Retrospective Cohort of 121 Patients With Dermatomyositis
Laurence Fardet et al.
MEDICINE (2009)
Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study
K. Fujikawa et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis
Hector Chinoy et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy
K. Kaji et al.
RHEUMATOLOGY (2007)
Malignancies in Korean patients with inflammatory myopathy
Sang-Won Lee et al.
YONSEI MEDICAL JOURNAL (2006)
Tumor antigen markers for the detection of solid cancers in inflammatory myopathies
Z Amoura et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Polymyositis - An overdiagnosed entity
MFG van der Meulen et al.
NEUROLOGY (2003)
Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study
N Wakata et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Routine vs extensive malignancy search for adult dermatomyositis and polymyositis -: A study of 40 patients
A Sparsa et al.
ARCHIVES OF DERMATOLOGY (2002)
Amyopathic dermatomyositis: Retrospective review of 37 cases
RA el-Azhary et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study
YJ Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
CL Hill et al.
LANCET (2001)
Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy
RE Hunger et al.
DERMATOLOGY (2001)
Share Paper
